Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Atul B. Shinagare, M.D.

Co-Author

This page shows the publications co-authored by Atul Shinagare and Katherine Krajewski.
Connection Strength

5.920
  1. Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities. Korean J Radiol. 2017 Jan-Feb; 18(1):28-41.
    View in: PubMed
    Score: 0.693
  2. Novel imaging in renal cell carcinoma. Curr Opin Urol. 2016 09; 26(5):388-95.
    View in: PubMed
    Score: 0.676
  3. Computed Tomography Texture Analysis for Predicting Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors. Oncologist. 2022 Mar 28.
    View in: PubMed
    Score: 0.249
  4. A review of the principles of texture analysis and its role in imaging of genitourinary neoplasms. Abdom Radiol (NY). 2019 07; 44(7):2501-2510.
    View in: PubMed
    Score: 0.206
  5. Radiogenomics in renal cell carcinoma. Abdom Radiol (NY). 2019 06; 44(6):1990-1998.
    View in: PubMed
    Score: 0.204
  6. Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer. Abdom Radiol (NY). 2017 11; 42(11):2710-2724.
    View in: PubMed
    Score: 0.183
  7. Advanced Renal Cell Carcinoma: Role of the Radiologist in the Era of Precision Medicine. Radiology. 2017 08; 284(2):333-351.
    View in: PubMed
    Score: 0.180
  8. Cancer Imaging Fellowship Training: Utility and Added Value in the Modern Era. J Am Coll Radiol. 2017 10; 14(10):1345-1348.
    View in: PubMed
    Score: 0.179
  9. T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes. Korean J Radiol. 2017 Jan-Feb; 18(1):71-83.
    View in: PubMed
    Score: 0.173
  10. Update on Radiogenomics of Clear Cell Renal Cell Carcinoma. Eur Urol Focus. 2016 Dec 15; 2(6):572-573.
    View in: PubMed
    Score: 0.172
  11. Multimodality imaging of locally recurrent and metastatic cervical cancer: emphasis on histology, prognosis, and management. Abdom Radiol (NY). 2016 12; 41(12):2496-2508.
    View in: PubMed
    Score: 0.172
  12. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients. Abdom Radiol (NY). 2016 Feb; 41(2):295-302.
    View in: PubMed
    Score: 0.162
  13. Metastatic Chordoma: Report of the Two Cases and Review of the Literature. Eurasian J Med. 2015 Jun; 47(2):151-4.
    View in: PubMed
    Score: 0.155
  14. Update on the role of imaging in management of metastatic colorectal cancer. Radiographics. 2014 Nov-Dec; 34(7):1908-28.
    View in: PubMed
    Score: 0.149
  15. Malignant skin and subcutaneous neoplasms in adults: multimodality imaging with CT, MRI, and 18F-FDG PET/CT. AJR Am J Roentgenol. 2014 May; 202(5):W422-38.
    View in: PubMed
    Score: 0.144
  16. Liver metastases in the era of molecular targeted therapy: new faces of treatment response. AJR Am J Roentgenol. 2013 Jul; 201(1):W15-28.
    View in: PubMed
    Score: 0.136
  17. MRI for evaluation of myeloid sarcoma in adults: a single-institution 10-year experience. AJR Am J Roentgenol. 2012 Dec; 199(6):1193-8.
    View in: PubMed
    Score: 0.130
  18. Pneumatosis intestinalis and bowel perforation associated with molecular targeted therapy: an emerging problem and the role of radiologists in its management. AJR Am J Roentgenol. 2012 Dec; 199(6):1259-65.
    View in: PubMed
    Score: 0.130
  19. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma. AJR Am J Roentgenol. 2012 Nov; 199(5):W554-64.
    View in: PubMed
    Score: 0.130
  20. Esophageal gastrointestinal stromal tumor: report of 7 patients. Cancer Imaging. 2012 Apr 27; 12:100-8.
    View in: PubMed
    Score: 0.125
  21. A to Z of desmoid tumors. AJR Am J Roentgenol. 2011 Dec; 197(6):W1008-14.
    View in: PubMed
    Score: 0.122
  22. Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center. Cancer. 2011 Aug 15; 117(16):3860-6.
    View in: PubMed
    Score: 0.115
  23. A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma. Eur Radiol. 2018 Jan; 28(1):214-225.
    View in: PubMed
    Score: 0.045
  24. Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors. Clin Radiol. 2017 Jul; 72(7):521-533.
    View in: PubMed
    Score: 0.044
  25. Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists. Radiographics. 2016 May-Jun; 36(3):767-82.
    View in: PubMed
    Score: 0.041
  26. A New Look at Toxicity in the Era of Precision Oncology: Imaging Findings, Their Relationship With Tumor Response, and Effect on Metastasectomy. AJR Am J Roentgenol. 2016 Jul; 207(1):4-14.
    View in: PubMed
    Score: 0.041
  27. Multimodality imaging of osseous involvement In haematological malignancies. Br J Radiol. 2016; 89(1059):20150980.
    View in: PubMed
    Score: 0.040
  28. Imaging of Fluid in Cancer Patients Treated With Systemic Therapy: Chemotherapy, Molecular Targeted Therapy, and Hematopoietic Stem Cell Transplantation. AJR Am J Roentgenol. 2015 Oct; 205(4):709-19.
    View in: PubMed
    Score: 0.040
  29. Extracutaneous melanomas: a primer for the radiologist. Insights Imaging. 2015 Dec; 6(6):707-17.
    View in: PubMed
    Score: 0.039
  30. Imaging of Nervous System Involvement in Hematologic Malignancies: What Radiologists Need to Know. AJR Am J Roentgenol. 2015 Sep; 205(3):604-17.
    View in: PubMed
    Score: 0.039
  31. MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experience. Br J Radiol. 2015 Sep; 88(1053):20150085.
    View in: PubMed
    Score: 0.039
  32. Hormonal therapy in oncology: a primer for the radiologist. AJR Am J Roentgenol. 2015 Jun; 204(6):W620-30.
    View in: PubMed
    Score: 0.039
  33. Beyond the vascular endothelial growth factor axis: update on role of imaging in nonantiangiogenic molecular targeted therapies in oncology. AJR Am J Roentgenol. 2015 May; 204(5):919-32.
    View in: PubMed
    Score: 0.039
  34. Esophageal Carcinoma: Current Concepts in the Role of Imaging in Staging and Management. Can Assoc Radiol J. 2015 May; 66(2):130-9.
    View in: PubMed
    Score: 0.038
  35. Anti-VEGF molecular targeted therapies in common solid malignancies: comprehensive update for radiologists. Radiographics. 2015 Mar-Apr; 35(2):455-74.
    View in: PubMed
    Score: 0.038
  36. Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management. Korean J Radiol. 2015 Mar-Apr; 16(2):304-13.
    View in: PubMed
    Score: 0.038
  37. Clinical and radiologic features of extraskeletal myxoid chondrosarcoma including initial presentation, local recurrence, and metastases. Radiol Oncol. 2014 Sep; 48(3):235-42.
    View in: PubMed
    Score: 0.036
  38. MRI features of extramedullary myeloma. AJR Am J Roentgenol. 2014 Apr; 202(4):803-10.
    View in: PubMed
    Score: 0.036
  39. Imaging of uncommon esophageal malignancies. Dis Esophagus. 2015 Aug-Sep; 28(6):552-9.
    View in: PubMed
    Score: 0.036
  40. Multidetector-row CT of tumour-bowel fistula: Experience at a tertiary cancer centre. Clin Radiol. 2014 Feb; 69(2):e100-7.
    View in: PubMed
    Score: 0.035
  41. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection. Eur J Surg Oncol. 2014 Apr; 40(4):420-8.
    View in: PubMed
    Score: 0.035
  42. Gallbladder complications associated with molecular targeted therapies: clinical and imaging features. Clin Imaging. 2014 Jan-Feb; 38(1):50-5.
    View in: PubMed
    Score: 0.035
  43. Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspective. AJR Am J Roentgenol. 2013 Oct; 201(4):801-10.
    View in: PubMed
    Score: 0.035
  44. Update on the management of gastroenteropancreatic neuroendocrine tumors with emphasis on the role of imaging. AJR Am J Roentgenol. 2013 Oct; 201(4):811-24.
    View in: PubMed
    Score: 0.035
  45. Acute pancreatitis associated with molecular targeted therapies: a retrospective review of the clinico-radiological features, management and outcome. Pancreatology. 2013 Sep-Oct; 13(5):461-7.
    View in: PubMed
    Score: 0.034
  46. Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up. Abdom Imaging. 2013 Aug; 38(4):728-35.
    View in: PubMed
    Score: 0.034
  47. Intrathoracic malignant peripheral nerve sheath tumors: imaging features and implications for management. Radiol Oncol. 2013; 47(3):230-8.
    View in: PubMed
    Score: 0.034
  48. Update on imaging of vulvar squamous cell carcinoma. AJR Am J Roentgenol. 2013 Jul; 201(1):W147-57.
    View in: PubMed
    Score: 0.034
  49. Merkel cell carcinoma: a primer for the radiologist. AJR Am J Roentgenol. 2013 Jun; 200(6):1186-96.
    View in: PubMed
    Score: 0.034
  50. Molecular targeted therapies in non-GIST soft tissue sarcomas: what the radiologist needs to know. Cancer Imaging. 2013 May 02; 13:197-211.
    View in: PubMed
    Score: 0.034
  51. Ipilimumab-associated colitis: CT findings. AJR Am J Roentgenol. 2013 May; 200(5):W468-74.
    View in: PubMed
    Score: 0.034
  52. Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know. AJR Am J Roentgenol. 2013 Mar; 200(3):484-92.
    View in: PubMed
    Score: 0.033
  53. Imaging features of primary anorectal gastrointestinal stromal tumors with clinical and pathologic correlation. Cancer Imaging. 2013 Feb 08; 12:557-65.
    View in: PubMed
    Score: 0.033
  54. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. Eur J Surg Oncol. 2013 Jan; 39(1):46-52.
    View in: PubMed
    Score: 0.032
  55. Imaging features of primary extranodal histiocytic sarcoma: report of two cases and a review of the literature. Cancer Imaging. 2012 Aug 10; 12:253-8.
    View in: PubMed
    Score: 0.032
  56. Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. AJR Am J Roentgenol. 2012 Aug; 199(2):W208-15.
    View in: PubMed
    Score: 0.032
  57. What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents. Emerg Radiol. 2012 Dec; 19(6):535-46.
    View in: PubMed
    Score: 0.032
  58. Imaging features of bowel toxicities in the setting of molecular targeted therapies in cancer patients. Br J Radiol. 2012 Oct; 85(1018):1420-6.
    View in: PubMed
    Score: 0.032
  59. Extrahepatic spread of hepatocellular carcinoma: spectrum of imaging findings. AJR Am J Roentgenol. 2011 Oct; 197(4):W658-64.
    View in: PubMed
    Score: 0.030
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.